Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1788375

Cover Image

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1788375

Tourette Syndrome Treatment

PUBLISHED:
PAGES: 186 Pages
DELIVERY TIME: 1-2 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
PDF (Single User License)
USD 5850
PDF (Global License to Company and its Fully-owned Subsidiaries)
USD 17550

Add to Cart

Description

Table of Contents

Global Tourette Syndrome Treatment Market to Reach US$3.1 Billion by 2030

The global market for Tourette Syndrome Treatment estimated at US$2.3 Billion in the year 2024, is expected to reach US$3.1 Billion by 2030, growing at a CAGR of 5.1% over the analysis period 2024-2030. Antipsychotics, one of the segments analyzed in the report, is expected to record a 4.1% CAGR and reach US$2.0 Billion by the end of the analysis period. Growth in the Non-Antipsychotics segment is estimated at 7.0% CAGR over the analysis period.

The U.S. Market is Estimated at US$626.0 Million While China is Forecast to Grow at 7.9% CAGR

The Tourette Syndrome Treatment market in the U.S. is estimated at US$626.0 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$609.9 Million by the year 2030 trailing a CAGR of 7.9% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.5% and 5.0% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.3% CAGR.

Tourette Syndrome Treatment Market Trends & Drivers Summarized

How Is Tourette Syndrome Treatment Advancing with Personalized Medicine and Neuromodulation?

Tourette Syndrome (TS) is a neurological disorder characterized by repetitive, involuntary tics and vocalizations, often appearing in childhood. While the exact cause remains unclear, research indicates a combination of genetic, neurological, and environmental factors. Historically, treatment options have been limited to behavioral therapy and pharmacological interventions, such as dopamine antagonists and alpha-adrenergic agonists. However, the growing emphasis on personalized medicine, neuromodulation techniques, and gene therapy is transforming the treatment landscape. Deep brain stimulation (DBS) and transcranial magnetic stimulation (TMS) are emerging as promising non-invasive solutions for severe cases, offering improved symptom control without the side effects associated with traditional medications. However, challenges such as delayed diagnosis, variability in symptom severity, and limited treatment accessibility persist. As neuropsychiatric research advances, how will innovations in targeted therapies and digital therapeutics redefine the future of Tourette Syndrome treatment?

What Technological Innovations Are Advancing Tourette Syndrome Treatment?

Recent breakthroughs in TS treatment focus on precision neuromodulation, AI-driven diagnostic tools, and pharmacogenomics. DBS, originally developed for Parkinson’s disease, is now being explored for TS, helping to regulate abnormal neural circuits. AI-based cognitive behavioral therapy (CBT) apps are enabling remote tic management, making treatment more accessible. Genetic research is uncovering potential biomarkers for TS, paving the way for targeted therapies tailored to individual patients. Additionally, wearable devices with real-time biofeedback mechanisms are emerging as digital therapeutics, helping individuals manage tics through neurofeedback and habit-reversal training.

Why Is the Demand for Tourette Syndrome Treatment Increasing?

The increasing prevalence of neurodevelopmental disorders, growing awareness of TS, and advancements in non-invasive neuromodulation are driving demand for innovative treatments. Parents and caregivers are seeking alternative therapies beyond medication due to concerns over side effects. Additionally, the rising adoption of telemedicine and digital therapeutics is expanding access to behavioral interventions, further fueling market growth.

What Factors Are Driving the Growth of the Tourette Syndrome Treatment Market?

The market is expanding due to advancements in neurostimulation therapies, increasing research into genetic and neurobiological mechanisms, growing demand for non-pharmacological treatments, and expanding digital health solutions. As the understanding of Tourette Syndrome improves, future treatments will likely focus on personalized and technology-driven interventions, enhancing patient outcomes and quality of life.

SCOPE OF STUDY:

The report analyzes the Tourette Syndrome Treatment market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Treatment Type (Antipsychotics, Non-Antipsychotics)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 48 Featured) -

  • AbbVie Inc.
  • Abide Therapeutics
  • Acorda Therapeutics
  • Anika Therapeutics Inc.
  • Apotex Inc.
  • Arbor Pharmaceuticals
  • AstraZeneca PLC
  • Bausch Health Companies Inc.
  • Bayer AG
  • Biogen Inc.
  • Boehringer Ingelheim International GmbH
  • Bristol-Myers Squibb
  • Catalyst Pharmaceuticals, Inc.
  • Eli Lilly and Company
  • Emalex Biosciences, Inc.
  • F. Hoffmann-La Roche AG
  • H. Lundbeck A/S
  • Janssen Pharmaceuticals, Inc.
  • Jazz Pharmaceuticals plc
  • Kyowa Kirin Co., Ltd.
  • Mitsubishi Tanabe Pharma Corporation
  • Neurocrine Biosciences, Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

Show more
Product Code: MCP33165

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Tourette Syndrome Treatment - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Increasing Diagnosis Rates and Awareness Campaigns Drive Demand for Therapeutic Options
    • Expansion of Behavioral Therapy Access Enhances Non-Pharmacologic Treatment Demand
    • Clinical Development of Dopamine Modulators and VMAT2 Inhibitors Advances Drug Pipeline
    • Rise in Pediatric Neuropsychiatry Services Strengthens Early Intervention Initiatives
    • Growing Research Into Comorbidity Management (ADHD, OCD) Expands Treatment Scope
    • Use of Digital CBT Tools and Virtual Consults Supports Decentralized Behavioral Therapies
    • Development of Long-Acting Injectable Formulations Improves Adherence and Quality of Life
    • Clinical Trials Targeting Genetic and Neurobiological Mechanisms Enhance Innovation
    • Regulatory Fast Track and Orphan Drug Status Incentivize R&D Investment
    • Integration of Multidisciplinary Care Models Improves Treatment Coordination
    • Advocacy Group Engagement and Support Networks Improve Patient Retention
    • Emerging Interest in Neuromodulation and DBS for Refractory Cases Expands Research Frontiers
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Tourette Syndrome Treatment Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Tourette Syndrome Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Tourette Syndrome Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Tourette Syndrome Treatment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Antipsychotics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Antipsychotics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Antipsychotics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Non-Antipsychotics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Non-Antipsychotics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Non-Antipsychotics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Tourette Syndrome Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 11: USA Recent Past, Current & Future Analysis for Tourette Syndrome Treatment by Treatment Type - Antipsychotics and Non-Antipsychotics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 12: USA Historic Review for Tourette Syndrome Treatment by Treatment Type - Antipsychotics and Non-Antipsychotics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 13: USA 15-Year Perspective for Tourette Syndrome Treatment by Treatment Type - Percentage Breakdown of Value Sales for Antipsychotics and Non-Antipsychotics for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 14: Canada Recent Past, Current & Future Analysis for Tourette Syndrome Treatment by Treatment Type - Antipsychotics and Non-Antipsychotics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 15: Canada Historic Review for Tourette Syndrome Treatment by Treatment Type - Antipsychotics and Non-Antipsychotics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 16: Canada 15-Year Perspective for Tourette Syndrome Treatment by Treatment Type - Percentage Breakdown of Value Sales for Antipsychotics and Non-Antipsychotics for the Years 2015, 2025 & 2030
  • JAPAN
    • Tourette Syndrome Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 17: Japan Recent Past, Current & Future Analysis for Tourette Syndrome Treatment by Treatment Type - Antipsychotics and Non-Antipsychotics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 18: Japan Historic Review for Tourette Syndrome Treatment by Treatment Type - Antipsychotics and Non-Antipsychotics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 19: Japan 15-Year Perspective for Tourette Syndrome Treatment by Treatment Type - Percentage Breakdown of Value Sales for Antipsychotics and Non-Antipsychotics for the Years 2015, 2025 & 2030
  • CHINA
    • Tourette Syndrome Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 20: China Recent Past, Current & Future Analysis for Tourette Syndrome Treatment by Treatment Type - Antipsychotics and Non-Antipsychotics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 21: China Historic Review for Tourette Syndrome Treatment by Treatment Type - Antipsychotics and Non-Antipsychotics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 22: China 15-Year Perspective for Tourette Syndrome Treatment by Treatment Type - Percentage Breakdown of Value Sales for Antipsychotics and Non-Antipsychotics for the Years 2015, 2025 & 2030
  • EUROPE
    • Tourette Syndrome Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 23: Europe Recent Past, Current & Future Analysis for Tourette Syndrome Treatment by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 24: Europe Historic Review for Tourette Syndrome Treatment by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 25: Europe 15-Year Perspective for Tourette Syndrome Treatment by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 26: Europe Recent Past, Current & Future Analysis for Tourette Syndrome Treatment by Treatment Type - Antipsychotics and Non-Antipsychotics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 27: Europe Historic Review for Tourette Syndrome Treatment by Treatment Type - Antipsychotics and Non-Antipsychotics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 28: Europe 15-Year Perspective for Tourette Syndrome Treatment by Treatment Type - Percentage Breakdown of Value Sales for Antipsychotics and Non-Antipsychotics for the Years 2015, 2025 & 2030
  • FRANCE
    • Tourette Syndrome Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 29: France Recent Past, Current & Future Analysis for Tourette Syndrome Treatment by Treatment Type - Antipsychotics and Non-Antipsychotics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 30: France Historic Review for Tourette Syndrome Treatment by Treatment Type - Antipsychotics and Non-Antipsychotics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 31: France 15-Year Perspective for Tourette Syndrome Treatment by Treatment Type - Percentage Breakdown of Value Sales for Antipsychotics and Non-Antipsychotics for the Years 2015, 2025 & 2030
  • GERMANY
    • Tourette Syndrome Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 32: Germany Recent Past, Current & Future Analysis for Tourette Syndrome Treatment by Treatment Type - Antipsychotics and Non-Antipsychotics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Germany Historic Review for Tourette Syndrome Treatment by Treatment Type - Antipsychotics and Non-Antipsychotics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: Germany 15-Year Perspective for Tourette Syndrome Treatment by Treatment Type - Percentage Breakdown of Value Sales for Antipsychotics and Non-Antipsychotics for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 35: Italy Recent Past, Current & Future Analysis for Tourette Syndrome Treatment by Treatment Type - Antipsychotics and Non-Antipsychotics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Italy Historic Review for Tourette Syndrome Treatment by Treatment Type - Antipsychotics and Non-Antipsychotics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: Italy 15-Year Perspective for Tourette Syndrome Treatment by Treatment Type - Percentage Breakdown of Value Sales for Antipsychotics and Non-Antipsychotics for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Tourette Syndrome Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 38: UK Recent Past, Current & Future Analysis for Tourette Syndrome Treatment by Treatment Type - Antipsychotics and Non-Antipsychotics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: UK Historic Review for Tourette Syndrome Treatment by Treatment Type - Antipsychotics and Non-Antipsychotics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: UK 15-Year Perspective for Tourette Syndrome Treatment by Treatment Type - Percentage Breakdown of Value Sales for Antipsychotics and Non-Antipsychotics for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 41: Spain Recent Past, Current & Future Analysis for Tourette Syndrome Treatment by Treatment Type - Antipsychotics and Non-Antipsychotics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Spain Historic Review for Tourette Syndrome Treatment by Treatment Type - Antipsychotics and Non-Antipsychotics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: Spain 15-Year Perspective for Tourette Syndrome Treatment by Treatment Type - Percentage Breakdown of Value Sales for Antipsychotics and Non-Antipsychotics for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 44: Russia Recent Past, Current & Future Analysis for Tourette Syndrome Treatment by Treatment Type - Antipsychotics and Non-Antipsychotics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Russia Historic Review for Tourette Syndrome Treatment by Treatment Type - Antipsychotics and Non-Antipsychotics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: Russia 15-Year Perspective for Tourette Syndrome Treatment by Treatment Type - Percentage Breakdown of Value Sales for Antipsychotics and Non-Antipsychotics for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 47: Rest of Europe Recent Past, Current & Future Analysis for Tourette Syndrome Treatment by Treatment Type - Antipsychotics and Non-Antipsychotics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Rest of Europe Historic Review for Tourette Syndrome Treatment by Treatment Type - Antipsychotics and Non-Antipsychotics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: Rest of Europe 15-Year Perspective for Tourette Syndrome Treatment by Treatment Type - Percentage Breakdown of Value Sales for Antipsychotics and Non-Antipsychotics for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Tourette Syndrome Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 50: Asia-Pacific Recent Past, Current & Future Analysis for Tourette Syndrome Treatment by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 51: Asia-Pacific Historic Review for Tourette Syndrome Treatment by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: Asia-Pacific 15-Year Perspective for Tourette Syndrome Treatment by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 53: Asia-Pacific Recent Past, Current & Future Analysis for Tourette Syndrome Treatment by Treatment Type - Antipsychotics and Non-Antipsychotics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Asia-Pacific Historic Review for Tourette Syndrome Treatment by Treatment Type - Antipsychotics and Non-Antipsychotics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: Asia-Pacific 15-Year Perspective for Tourette Syndrome Treatment by Treatment Type - Percentage Breakdown of Value Sales for Antipsychotics and Non-Antipsychotics for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Tourette Syndrome Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 56: Australia Recent Past, Current & Future Analysis for Tourette Syndrome Treatment by Treatment Type - Antipsychotics and Non-Antipsychotics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Australia Historic Review for Tourette Syndrome Treatment by Treatment Type - Antipsychotics and Non-Antipsychotics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: Australia 15-Year Perspective for Tourette Syndrome Treatment by Treatment Type - Percentage Breakdown of Value Sales for Antipsychotics and Non-Antipsychotics for the Years 2015, 2025 & 2030
  • INDIA
    • Tourette Syndrome Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 59: India Recent Past, Current & Future Analysis for Tourette Syndrome Treatment by Treatment Type - Antipsychotics and Non-Antipsychotics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: India Historic Review for Tourette Syndrome Treatment by Treatment Type - Antipsychotics and Non-Antipsychotics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: India 15-Year Perspective for Tourette Syndrome Treatment by Treatment Type - Percentage Breakdown of Value Sales for Antipsychotics and Non-Antipsychotics for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 62: South Korea Recent Past, Current & Future Analysis for Tourette Syndrome Treatment by Treatment Type - Antipsychotics and Non-Antipsychotics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: South Korea Historic Review for Tourette Syndrome Treatment by Treatment Type - Antipsychotics and Non-Antipsychotics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: South Korea 15-Year Perspective for Tourette Syndrome Treatment by Treatment Type - Percentage Breakdown of Value Sales for Antipsychotics and Non-Antipsychotics for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 65: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Tourette Syndrome Treatment by Treatment Type - Antipsychotics and Non-Antipsychotics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Rest of Asia-Pacific Historic Review for Tourette Syndrome Treatment by Treatment Type - Antipsychotics and Non-Antipsychotics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: Rest of Asia-Pacific 15-Year Perspective for Tourette Syndrome Treatment by Treatment Type - Percentage Breakdown of Value Sales for Antipsychotics and Non-Antipsychotics for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Tourette Syndrome Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 68: Latin America Recent Past, Current & Future Analysis for Tourette Syndrome Treatment by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 69: Latin America Historic Review for Tourette Syndrome Treatment by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 70: Latin America 15-Year Perspective for Tourette Syndrome Treatment by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 71: Latin America Recent Past, Current & Future Analysis for Tourette Syndrome Treatment by Treatment Type - Antipsychotics and Non-Antipsychotics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Latin America Historic Review for Tourette Syndrome Treatment by Treatment Type - Antipsychotics and Non-Antipsychotics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 73: Latin America 15-Year Perspective for Tourette Syndrome Treatment by Treatment Type - Percentage Breakdown of Value Sales for Antipsychotics and Non-Antipsychotics for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 74: Argentina Recent Past, Current & Future Analysis for Tourette Syndrome Treatment by Treatment Type - Antipsychotics and Non-Antipsychotics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Argentina Historic Review for Tourette Syndrome Treatment by Treatment Type - Antipsychotics and Non-Antipsychotics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 76: Argentina 15-Year Perspective for Tourette Syndrome Treatment by Treatment Type - Percentage Breakdown of Value Sales for Antipsychotics and Non-Antipsychotics for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 77: Brazil Recent Past, Current & Future Analysis for Tourette Syndrome Treatment by Treatment Type - Antipsychotics and Non-Antipsychotics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Brazil Historic Review for Tourette Syndrome Treatment by Treatment Type - Antipsychotics and Non-Antipsychotics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 79: Brazil 15-Year Perspective for Tourette Syndrome Treatment by Treatment Type - Percentage Breakdown of Value Sales for Antipsychotics and Non-Antipsychotics for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 80: Mexico Recent Past, Current & Future Analysis for Tourette Syndrome Treatment by Treatment Type - Antipsychotics and Non-Antipsychotics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Mexico Historic Review for Tourette Syndrome Treatment by Treatment Type - Antipsychotics and Non-Antipsychotics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 82: Mexico 15-Year Perspective for Tourette Syndrome Treatment by Treatment Type - Percentage Breakdown of Value Sales for Antipsychotics and Non-Antipsychotics for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 83: Rest of Latin America Recent Past, Current & Future Analysis for Tourette Syndrome Treatment by Treatment Type - Antipsychotics and Non-Antipsychotics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Rest of Latin America Historic Review for Tourette Syndrome Treatment by Treatment Type - Antipsychotics and Non-Antipsychotics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 85: Rest of Latin America 15-Year Perspective for Tourette Syndrome Treatment by Treatment Type - Percentage Breakdown of Value Sales for Antipsychotics and Non-Antipsychotics for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Tourette Syndrome Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 86: Middle East Recent Past, Current & Future Analysis for Tourette Syndrome Treatment by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 87: Middle East Historic Review for Tourette Syndrome Treatment by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 88: Middle East 15-Year Perspective for Tourette Syndrome Treatment by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 89: Middle East Recent Past, Current & Future Analysis for Tourette Syndrome Treatment by Treatment Type - Antipsychotics and Non-Antipsychotics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Middle East Historic Review for Tourette Syndrome Treatment by Treatment Type - Antipsychotics and Non-Antipsychotics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 91: Middle East 15-Year Perspective for Tourette Syndrome Treatment by Treatment Type - Percentage Breakdown of Value Sales for Antipsychotics and Non-Antipsychotics for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 92: Iran Recent Past, Current & Future Analysis for Tourette Syndrome Treatment by Treatment Type - Antipsychotics and Non-Antipsychotics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Iran Historic Review for Tourette Syndrome Treatment by Treatment Type - Antipsychotics and Non-Antipsychotics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 94: Iran 15-Year Perspective for Tourette Syndrome Treatment by Treatment Type - Percentage Breakdown of Value Sales for Antipsychotics and Non-Antipsychotics for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 95: Israel Recent Past, Current & Future Analysis for Tourette Syndrome Treatment by Treatment Type - Antipsychotics and Non-Antipsychotics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Israel Historic Review for Tourette Syndrome Treatment by Treatment Type - Antipsychotics and Non-Antipsychotics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 97: Israel 15-Year Perspective for Tourette Syndrome Treatment by Treatment Type - Percentage Breakdown of Value Sales for Antipsychotics and Non-Antipsychotics for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 98: Saudi Arabia Recent Past, Current & Future Analysis for Tourette Syndrome Treatment by Treatment Type - Antipsychotics and Non-Antipsychotics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Saudi Arabia Historic Review for Tourette Syndrome Treatment by Treatment Type - Antipsychotics and Non-Antipsychotics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 100: Saudi Arabia 15-Year Perspective for Tourette Syndrome Treatment by Treatment Type - Percentage Breakdown of Value Sales for Antipsychotics and Non-Antipsychotics for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 101: UAE Recent Past, Current & Future Analysis for Tourette Syndrome Treatment by Treatment Type - Antipsychotics and Non-Antipsychotics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: UAE Historic Review for Tourette Syndrome Treatment by Treatment Type - Antipsychotics and Non-Antipsychotics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 103: UAE 15-Year Perspective for Tourette Syndrome Treatment by Treatment Type - Percentage Breakdown of Value Sales for Antipsychotics and Non-Antipsychotics for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 104: Rest of Middle East Recent Past, Current & Future Analysis for Tourette Syndrome Treatment by Treatment Type - Antipsychotics and Non-Antipsychotics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Rest of Middle East Historic Review for Tourette Syndrome Treatment by Treatment Type - Antipsychotics and Non-Antipsychotics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 106: Rest of Middle East 15-Year Perspective for Tourette Syndrome Treatment by Treatment Type - Percentage Breakdown of Value Sales for Antipsychotics and Non-Antipsychotics for the Years 2015, 2025 & 2030
  • AFRICA
    • Tourette Syndrome Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 107: Africa Recent Past, Current & Future Analysis for Tourette Syndrome Treatment by Treatment Type - Antipsychotics and Non-Antipsychotics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Africa Historic Review for Tourette Syndrome Treatment by Treatment Type - Antipsychotics and Non-Antipsychotics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 109: Africa 15-Year Perspective for Tourette Syndrome Treatment by Treatment Type - Percentage Breakdown of Value Sales for Antipsychotics and Non-Antipsychotics for the Years 2015, 2025 & 2030

IV. COMPETITION

Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!